Literature DB >> 31724147

Assessment of the effects of dysphagia therapy in patients in the early post-stroke period: a randomised controlled trial.

Edyta Krajczy1, Marcin Krajczy1,2, Jacek Luniewski3, Katarzyna Bogacz2, Jan Szczegielniak2.   

Abstract

AIM: This study aimed to evaluate the effects of dysphagia therapy in patients in the early post-stroke period. CLINICAL RATIONALE: Dysphagia can be one of the consequences of stroke. This problem often leads to complications in the early stages of stroke, including aspiration pneumonia. Although individual reports on dysphagia exist in the literature, no comprehensive guidelines for dysphagia therapy are available.
MATERIAL AND METHODS: This randomised controlled trial included 60 patients with swallowing difficulties after ischaemic stroke (30 each in the study and control groups; age range: 55-65 years) who were admitted to a hospital stroke subunit. Patient rehabilitation period covered 15 days (seven days a week), with therapy for the first 10 days provided during patient hospitalisation and then outpatient physiotherapy during the subsequent five days. The procedure, including providing education about safe food and liquid consumption to patients and their caregivers, was performed in both patient groups. An original dysphagia treatment method was employed in the study group. Statistical average, standard deviation, and statistical error before and after therapy were determined in the study and control groups. The significance of differences in results between the study and control groups was assessed using the Mann-Whitney U test.
RESULTS: The applied therapy for dysphagia improved the swallowing function and selected motor functions of patients after stroke. In the study group, ineffective (delayed) and absent swallowing reflex was observed in 13 patients (44%) before therapy and in one patient (3%) after therapy. The rate of effective swallowing reflex increased from 57% to 97%. Statistically significant differences in swallowing reflex were observed between the study and control groups after therapy (p = 0.00001).
CONCLUSIONS: A comprehensive therapy for dysphagia is effective and can reduce serious complications of swallowing disorders in clinical practice. CLINICAL IMPLICATIONS: The results of this study could improve the clinical treatment of dysphagia.

Entities:  

Keywords:  dysphagia; neurology; physiotherapy; stroke; swallowing

Mesh:

Year:  2019        PMID: 31724147     DOI: 10.5603/PJNNS.a2019.0053

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  4 in total

1.  Consensus on the Objectives of an Educational Intervention for Patients with Oropharyngeal Dysphagia and Their Informal Caregivers: A Delphi Study.

Authors:  Zahya Ghaddar; Nayla Matar; Joyce Noujaim; Anh Nguyet Diep; Aline Tohmé; Benoit Pétré
Journal:  Patient Prefer Adherence       Date:  2022-06-23       Impact factor: 2.314

2.  The Efficiency of Spa Rehabilitation in Chronic Ischemic Stroke Patients-Preliminary Reports.

Authors:  Bogumiła Pniak; Justyna Leszczak; Jadwiga Kurczab; Aleksandra Krzemińska; Joanna Pięta; Agnieszka Plis; Ewelina Czenczek-Lewandowska; Agnieszka Guzik
Journal:  Brain Sci       Date:  2021-04-15

3.  Design and implementation of botulinum toxin on cricopharyngeal dysfunction guided by a combination of catheter balloon, ultrasound, and electromyography (BECURE) in patients with stroke: study protocol for a randomized, double-blinded, placebo-controlled trial.

Authors:  Mengshu Xie; Zulin Dou; Guifang Wan; Peishan Zeng; Hongmei Wen
Journal:  Trials       Date:  2021-03-31       Impact factor: 2.279

Review 4.  Behavioural Interventions in People with Oropharyngeal Dysphagia: A Systematic Review and Meta-Analysis of Randomised Clinical Trials.

Authors:  Renée Speyer; Reinie Cordier; Anna-Liisa Sutt; Lianne Remijn; Bas Joris Heijnen; Mathieu Balaguer; Timothy Pommée; Michelle McInerney; Liza Bergström
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.